Danielle Guidaben, MD
Hospitalist · Redlands, CANPI 1316575624
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,441 of the $1,761 with a category attached, or 81.8%. It is spread thinly across 30 manufacturers, the largest accounting for just 15.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,365, more than ten times the $29 reported in 2023. Among hospitalist clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 52 payments — averaging $33.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$267
- Lilly USA, LLC$152
- AstraZeneca$104
- Seagen Inc.$100
- Genentech USA, Inc.$85
- Agios Pharmaceuticals, Inc.$83
- plus $969 from 24 others
What the payments were for
- Food & beverage$1,44182%
- Education$32018%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 6 | $267 |
| Lilly USA, LLC | 2 | $152 |
| AstraZeneca | 4 | $104 |
| Seagen Inc. | 1 | $100 |
| Genentech USA, Inc. | 3 | $85 |
| Agios Pharmaceuticals, Inc. | 3 | $83 |
| AbbVie | 3 | $74 |
| Beone Medicines USA, Inc. | 2 | $72 |
| Jazz Pharmaceuticals Inc. | 2 | $71 |
| Pfizer | 2 | $71 |
| Gilead | 2 | $60 |
| Daiichi Sankyo Inc. | 2 | $54 |
| Menarini Silicon Biosystems, Inc. | 2 | $53 |
| Kyowa Kirin, Inc. | 2 | $50 |
| Exelixis Inc. | 1 | $41 |
| Blueprint Medicines Corporation | 1 | $36 |
| ADC Therapeutics America, Inc. | 1 | $33 |
| Merck | 1 | $32 |
| Sanofi | 1 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Bristol Myers Squibb | 1 | $30 |
| Deciphera Pharmaceuticals Inc. | 1 | $29 |
| Novartis | 1 | $29 |
| Beigene USA, Inc. | 1 | $29 |
| X4 Pharmaceuticals, Inc. | 1 | $28 |
| Bayer | 1 | $26 |
| Karyopharm Therapeutics Inc. | 1 | $26 |
| Geron Corporation | 1 | $24 |
| E.r. Squibb & Sons, L.L.C. | 1 | $21 |
| AVEO Pharmaceuticals, Inc. | 1 | $20 |
How this compares
$1,761 in reported general payments places this provider in the 95th percentile of 2,469 hospitalist providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hospitalist in Redlands
- Mohitkumar ArdeshanaRedlands$10K
- Jennifer SchneiderSanta Rosa$1.2M
- Soham ShahBakersfield$844K
- Alpesh AminOrange$428K
- Retha GoodglickSanta Monica$156K
- Robert WachterSan Francisco$75K
- Steven WongTorrance$36K
- Edward LeeLos Angeles$30K
- Anjani KolahiOrange$30K
- Omar AldaasSan Diego$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.